The New England journal of medicine, 2021-12, Vol.385 (23), p.2123-2131
- Harter, Philipp
- Sehouli, Jalid
- Vergote, Ignace
- Ferron, Gwenael
- Reuss, Alexander
- Meier, Werner
- Greggi, Stefano
- Mosgard, Berit J
- Selle, Frederic
- Guyon, Frédéric
- Pomel, Christophe
- Lécuru, Fabrice
- Zang, Rongyu
- Avall-Lundqvist, Elisabeth
- Kim, Jae-Weon
- Ponce, Jordi
- Raspagliesi, Francesco
- Kristensen, Gunnar
- Classe, Jean-Marc
- Hillemanns, Peter
- Jensen, Pernille
- Hasenburg, Annette
- Ghaem-Maghami, Sadaf
- Mirza, Mansoor R
- Lund, Bente
- Reinthaller, Alexander
- Santaballa, Ana
- Olaitan, Adeola
- Hilpert, Felix
- du Bois, Andreas
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Harter, Philipp
- Sehouli, Jalid
- Vergote, Ignace
- Ferron, Gwenael
- Reuss, Alexander
- Meier, Werner
- Greggi, Stefano
- Mosgard, Berit J
- Selle, Frederic
- Guyon, Frédéric
- Pomel, Christophe
- Lécuru, Fabrice
- Zang, Rongyu
- Avall-Lundqvist, Elisabeth
- Kim, Jae-Weon
- Ponce, Jordi
- Raspagliesi, Francesco
- Kristensen, Gunnar
- Classe, Jean-Marc
- Hillemanns, Peter
- Jensen, Pernille
- Hasenburg, Annette
- Ghaem-Maghami, Sadaf
- Mirza, Mansoor R
- Lund, Bente
- Reinthaller, Alexander
- Santaballa, Ana
- Olaitan, Adeola
- Hilpert, Felix
- du Bois, Andreas
- Titel
- Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
- Ist Teil von
- The New England journal of medicine, 2021-12, Vol.385 (23), p.2123-2131
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Quelle
- Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
- Beschreibungen/Notizen
- Patients with platinum-sensitive relapsed ovarian cancer who had undergone complete resection were assigned to undergo surgery and then receive chemotherapy or to receive chemotherapy alone. The median overall survival was 54 months with surgery and chemotherapy, and 46 months with chemotherapy alone.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2103294Titel-ID: cdi_swepub_primary_oai_prod_swepub_kib_ki_se_148936509
- Format
- –
- Schlagworte
- Aged, Antineoplastic Agents - therapeutic use, Ascites, Cancer, Cancer therapies, Care and treatment, Chemotherapy, Combined Modality Therapy, Cytoreduction Surgical Procedures, Female, Gynecologic Oncology, Gynecology, Hematology, Humans, Medicin och hälsovetenskap, Middle Aged, Neoplasm Recurrence, Local - drug therapy, Neoplasm Recurrence, Local - mortality, Neoplasm Recurrence, Local - surgery, Obstetrics, Oncology, Ovarian cancer, Ovarian Neoplasms - drug therapy, Ovarian Neoplasms - mortality, Ovarian Neoplasms - surgery, Patient outcomes, Patients, Platinum, Proportional Hazards Models, Quality of Life, Relapse, Statistical analysis, Surgery, Surgery General, Survival, Survival Analysis, Treatments in Oncology